Notice of Republication
This article was republished on September 15, 2014, to correct typesetting errors involving missing minus symbols throughout the text and tables. The publisher apologizes for these errors. Please download this article again to view the article. The originally published, uncorrected article and the republished, corrected article are provided here for reference.
Supporting Information
File S1PDF
Originally published, uncorrected article
Click here for additional data file. (733.5KB, pdf)
File S2PDF
Republished, corrected article
Click here for additional data file. (772.1KB, pdf)
Reference
- 1. Sha S, Devineni D, Ghosh A, Polidori D, Hompesch M, et al. (2014) Pharmacodynamic Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, from a Randomized Study in Patients with Type 2 Diabetes. PLoS ONE 9(8): e105638 doi:10.1371/journal.pone.0105638 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
File S1PDF
Originally published, uncorrected article
Click here for additional data file. (733.5KB, pdf)
File S2PDF
Republished, corrected article
Click here for additional data file. (772.1KB, pdf)